{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:07:23Z","timestamp":1790381243522,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1038\/jid.2014.529","type":"journal-article","created":{"date-parts":[[2014,12,18]],"date-time":"2014-12-18T09:48:29Z","timestamp":1418896109000},"page":"1080-1088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Simvastatin Prevents and Reverses Depigmentation in a Mouse Model of Vitiligo"],"prefix":"10.1016","volume":"135","author":[{"given":"Priti","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Rashighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingsley I.","family":"Essien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian M.","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Pazoki-Toroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2014.529_bb0010","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A road map for those who don\u2019t know JAK-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science"},{"key":"10.1038\/jid.2014.529_bb0015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2310\/7750.2011.10068","article-title":"Worsening of vitiligo and onset of new psoriasiform dermatitis following treatment with infliximab","volume":"15","author":"Alghamdi","year":"2011","journal-title":"J Cutan Med Surg"},{"key":"10.1038\/jid.2014.529_bb0020","first-page":"534","article-title":"Treatment of generalized vitiligo with anti-TNF-alpha agents","volume":"11","author":"Alghamdi","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1038\/jid.2014.529_bb0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2014.529_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13555-012-0009-3","article-title":"Effect of biologic agents on non-PASI outcomes in moderate-to-severe plaque psoriasis: systematic review and meta-analyses","volume":"2","author":"Baker","year":"2012","journal-title":"Dermatol Ther"},{"key":"10.1038\/jid.2014.529_bb0035","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","article-title":"The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology","volume":"55","author":"Bickers","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2014.529_bb0040","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1371\/journal.pgen.0020131","article-title":"Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease","volume":"2","author":"Chapgier","year":"2006","journal-title":"PLoS Genet"},{"key":"10.1038\/jid.2014.529_bb0045","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.4049\/jimmunol.176.8.5078","article-title":"Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo","volume":"176","author":"Chapgier","year":"2006","journal-title":"J Immunol"},{"key":"10.1038\/jid.2014.529_bb0050","first-page":"159","article-title":"Failure of alefacept in the treatment of vitiligo","volume":"12","author":"Dayel","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1038\/jid.2014.529_bb0055","doi-asserted-by":"crossref","first-page":"g3743","DOI":"10.1136\/bmj.g3743","article-title":"Non-cardiovascular effects associated with statins","volume":"349","author":"Desai","year":"2014","journal-title":"BMJ"},{"key":"10.1038\/jid.2014.529_bb0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI200113152","article-title":"HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase\/Akt pathway","volume":"108","author":"Dimmeler","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2014.529_bb0065","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.1061154","article-title":"Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation","volume":"293","author":"Dupuis","year":"2001","journal-title":"Science"},{"key":"10.1038\/jid.2014.529_bb0070","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2014.529_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2004.02.016","article-title":"Statin-induced immunomodulatory effects on human T cells in vivo","volume":"175","author":"Fehr","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1038\/jid.2014.529_bb0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/CS20090603","article-title":"Vitiligo, reactive oxygen species and T-cells","volume":"120","author":"Glassman","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"10.1038\/jid.2014.529_bb0085","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/jid.2014.529_bb0090","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.529_bb0095","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1172\/JCI109938","article-title":"Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase","volume":"66","author":"Kita","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2014.529_bb0100","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.187.10.1565","article-title":"Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor","volume":"187","author":"Kunisada","year":"1998","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2014.529_bb0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/exd.12103","article-title":"Vitiligo: interplay between oxidative stress and immune system","volume":"22","author":"Laddha","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1038\/jid.2014.529_bb0110","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.170.3.1524","article-title":"A novel anti-inflammatory role for simvastatin in inflammatory arthritis","volume":"170","author":"Leung","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/jid.2014.529_bb0115","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/jcb.22976","article-title":"Molecular mechanisms underlying the inhibition of IFN-gamma-induced, STAT1-mediated gene transcription in human macrophages by simvastatin and agonists of PPARs and LXRs","volume":"112","author":"Li","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1038\/jid.2014.529_bb0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.03.022","article-title":"The burden of vitiligo: patient characteristics associated with quality of life","volume":"61","author":"Linthorst Homan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2014.529_bb0125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0092-8674(00)81288-X","article-title":"Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway","volume":"84","author":"Meraz","year":"1996","journal-title":"Cell"},{"key":"10.1038\/jid.2014.529_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1755-148X.2011.00916.x","article-title":"HSP70i is a critical component of the immune response leading to vitiligo","volume":"25","author":"Mosenson","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1038\/jid.2014.529_bb0135","doi-asserted-by":"crossref","first-page":"174ra28","DOI":"10.1126\/scitranslmed.3005127","article-title":"Mutant HSP70 reverses autoimmune depigmentation in vitiligo","volume":"5","author":"Mosenson","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1038\/jid.2014.529_bb0140","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"},{"key":"10.1038\/jid.2014.529_bb0145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/hh1701.096614","article-title":"Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis","volume":"89","author":"Ni","year":"2001","journal-title":"Circ Res"},{"key":"10.1038\/jid.2014.529_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-511X-3-7","article-title":"Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo","volume":"3","author":"Noel","year":"2004","journal-title":"Lipids Health Dis"},{"key":"10.1038\/jid.2014.529_bb0155","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2014.529_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2005.01369.x","article-title":"Psychosocial effects of vitiligo","volume":"20","author":"Ongenae","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1038\/jid.2014.529_bb0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdermsci.2006.04.006","article-title":"Topical simvastatin: preclinical evidence for a treatment of skin inflammatory conditions","volume":"44","author":"Otuki","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2014.529_bb0170","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20030590","article-title":"Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells","volume":"198","author":"Overwijk","year":"2003","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2014.529_bb0175","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.188.2.277","article-title":"gp100\/pmel 17 is a murine tumor rejection antigen: induction of \"self\"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand","volume":"188","author":"Overwijk","year":"1998","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2014.529_bb0180","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1038\/jid.2012.328","article-title":"Activation of the unfolded protein response in vitiligo: the missing link?","volume":"132","author":"Passeron","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.529_bb0185","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1073\/pnas.111164198","article-title":"Stat1-independent regulation of gene expression in response to IFN-gamma","volume":"98","author":"Ramana","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2014.529_bb0190","doi-asserted-by":"crossref","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1038\/jid.2014.529_bb0195","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.4049\/jimmunol.165.5.2712","article-title":"Simvastatin modulates cytokine-mediated endothelial cell adhesion molecule induction: involvement of an inhibitory G protein","volume":"165","author":"Sadeghi","year":"2000","journal-title":"J Immunol"},{"key":"10.1038\/jid.2014.529_bb0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0625.2007.00666_1.x","article-title":"Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?","volume":"17","author":"Schallreuter","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1038\/jid.2014.529_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1038\/jid.2014.529_bb0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1684\/ejd.2012.1884","article-title":"Oxidative stress and autoimmune skin disease","volume":"23","author":"Shah","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1038\/jid.2014.529_bb0215","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/jid.2011.321","article-title":"Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis","volume":"132","author":"Spritz","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.529_bb0220","first-page":"739","article-title":"The role of statins in cancer prevention and treatment","volume":"19","author":"Stamm","year":"2005","journal-title":"Oncology (Williston Park)"},{"key":"10.1038\/jid.2014.529_bb0225","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/jid.2012.181","article-title":"Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8","volume":"132","author":"Toosi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.529_bb0230","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1100102","article-title":"STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis","volume":"365","author":"van de Veerdonk","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2014.529_bb0235","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.529_bb0240","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1755-148X.2011.00878.x","article-title":"Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity","volume":"24","author":"van den Boorn","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1038\/jid.2014.529_bb0245","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/jid.2011.41","article-title":"Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita","volume":"131","author":"Zhao","year":"2011","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15372006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15372006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:54:49Z","timestamp":1743962089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15372006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0022202X15372006"],"URL":"https:\/\/doi.org\/10.1038\/jid.2014.529","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725282599.793522590","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simvastatin Prevents and Reverses Depigmentation in a Mouse Model of Vitiligo","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2014.529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}